Consumer Discretionary • Catalog/Specialty Distribution
$16.89 ▲ +0.18
(+1.08%)
MKT CAP: $3.00B • VOL: 848.2K
52W L $9 52W H $30
PTRN // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.50B | $1.80B | $1.37B |
| YoY Revenue Growth % | +39.3% | +31.5% | — |
| Gross Profit | $1.09B | $781.3M | — |
| Gross Margin % | 43.6% | 43.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $25.4M | $87.2M | $52.8M |
| Operating Margin % | 1.0% | 4.9% | 3.9% |
| Net Income (GAAP) | $16.2M | $67.9M | $41.3M |
| EBITDA (Normalized) | $41.8M | $103.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $99.4M | $70.3M | $41.5M |
| Capital Expenditures (CapEx) | $20.5M | $20.4M | — |
| Free Cash Flow (FCF) | $78.9M | $49.9M | $41.5M |
| FCF Margin % | 3.2% | 2.8% | 3.0% |
| Return on Invested Capital (ROIC %) | 6.9% | 95.0% | — |
| Cash & Short-Term Equivalents | $289.0M | $175.6M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $581.0M | $108.7M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR PTRN.